Servet Gayrimenkul Yatirim Ortakligi A.S. (IST:SRVGY)
Turkey · Delayed Price · Currency is TRY 3.250
+0.020 (0.62%)
At close: Aug 1, 2025, 6:00 PM GMT+3
Ligand Pharmaceuticals Revenue
Servet Gayrimenkul Yatirim Ortakligi A.S. had revenue of 341.59M TRY in the quarter ending March 31, 2025, with 15.97% growth. This brings the company's revenue in the last twelve months to 1.32B, down -14.47% year-over-year. In the year 2024, Servet Gayrimenkul Yatirim Ortakligi A.S. had annual revenue of 1.28B, down -10.34%.
Revenue (ttm)
1.32B
Revenue Growth
-14.47%
P/S Ratio
8.25
Revenue / Employee
35.76M
Employees
29
Market Cap
10.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.28B | -147.18M | -10.34% |
| Dec 31, 2023 | 1.42B | -154.79M | -9.81% |
| Dec 31, 2022 | 1.58B | 1.16B | 280.99% |
| Dec 31, 2021 | 414.24M | -892.29M | -68.29% |
| Dec 31, 2020 | 1.31B | 1.21B | 1,259.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition